Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Preliminary efficacy results
Por:
Isla D, Arriola E, Campelo M, Tain P, Blanco C, Piqueras M, Vega A, Mateos L, Rodriguez J, Calderon V, Tarruella M, Hernandez A, de la Rosa C, Cabellos R, Ciriquian J, Paul A, Perez J, Mellen A, Baez L, Paz-Ares L
Publicada:
1 sep 2022
Ahead of Print:
1 sep 2022
Resumen:
|